Madrigal Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Madrigal Pharmaceuticals 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About MDGL

Madrigal Pharmaceuticals, Inc. engages in the development and commercialization of therapeutics for metabolic dysfunction-associated steatohepatitis. The company was founded by Rebecca A. 

CEO
William J. Sibold
CEOWilliam J. Sibold
Employees
915
Employees915
Headquarters
West Conshohocken, Pennsylvania
HeadquartersWest Conshohocken, Pennsylvania
Founded
2000
Founded2000
Employees
915
Employees915

MDGL Key Statistics

Market cap
10.78B
Market cap10.78B
Price-Earnings ratio
-36.27
Price-Earnings ratio-36.27
Dividend yield
Dividend yield
Average volume
419.21K
Average volume419.21K
High today
$495.00
High today$495.00
Low today
$460.11
Low today$460.11
Open price
$490.44
Open price$490.44
Volume
795.02K
Volume795.02K
52 Week high
$615.00
52 Week high$615.00
52 Week low
$298.00
52 Week low$298.00

Stock Snapshot

With a market cap of 10.78B, Madrigal Pharmaceuticals(MDGL) trades at $467.32. The stock has a price-to-earnings ratio of -36.27.

As of 2026-08-01, Madrigal Pharmaceuticals(MDGL) stock has fluctuated between $460.11 and $495.00. The current price stands at $467.32, placing the stock +1.6% above today's low and -5.6% off the high.

Madrigal Pharmaceuticals(MDGL) shares are trading with a volume of 795.02K, against a daily average of 419.21K.

In the last year, Madrigal Pharmaceuticals(MDGL) shares hit a 52-week high of $615.00 and a 52-week low of $298.00.

In the last year, Madrigal Pharmaceuticals(MDGL) shares hit a 52-week high of $615.00 and a 52-week low of $298.00.

MDGL News

Investing.com 1d
Madrigal Pharma earnings beat by $0.74, revenue topped estimates - Investing.com

...

Madrigal Pharma earnings beat by $0.74, revenue topped estimates - Investing.com

Analyst ratings

89%

of 19 ratings
Buy
89.5%
Hold
10.5%
Sell
0%

People also own

Based on the portfolios of people who own MDGL. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.